IE53104B1 - Process for the control of the liberation of active materials from active material containing compositions - Google Patents

Process for the control of the liberation of active materials from active material containing compositions

Info

Publication number
IE53104B1
IE53104B1 IE1201/82A IE120182A IE53104B1 IE 53104 B1 IE53104 B1 IE 53104B1 IE 1201/82 A IE1201/82 A IE 1201/82A IE 120182 A IE120182 A IE 120182A IE 53104 B1 IE53104 B1 IE 53104B1
Authority
IE
Ireland
Prior art keywords
liberation
active material
viscosity
active
process according
Prior art date
Application number
IE1201/82A
Other versions
IE821201L (en
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6135462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE53104(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of IE821201L publication Critical patent/IE821201L/en
Publication of IE53104B1 publication Critical patent/IE53104B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10Macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • CCHEMISTRY; METALLURGY
    • C05FERTILISERS; MANUFACTURE THEREOF
    • C05GMIXTURES OF FERTILISERS COVERED INDIVIDUALLY BY DIFFERENT SUBCLASSES OF CLASS C05; MIXTURES OF ONE OR MORE FERTILISERS WITH MATERIALS NOT HAVING A SPECIFIC FERTILISING ACTIVITY, e.g. PESTICIDES, SOIL-CONDITIONERS, WETTING AGENTS; FERTILISERS CHARACTERISED BY THEIR FORM
    • C05G3/00Mixtures of one or more fertilisers with additives not having a specially fertilising activity
    • C05G3/40Mixtures of one or more fertilisers with additives not having a specially fertilising activity for affecting fertiliser dosage or release rate; for affecting solubility
    • C05G3/44Mixtures of one or more fertilisers with additives not having a specially fertilising activity for affecting fertiliser dosage or release rate; for affecting solubility for affecting solubility

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lock And Its Accessories (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Materials For Medical Uses (AREA)

Abstract

1. Process for the time controlled release of active substances from sustained-release active substance preparations, in particular drug preparations, by addition of hydrophilic polymers characterized in that the release rate which is rising as a result of increasing viscosity steps of the hydrophilic polymers added is empirically determined and the desired release characteristic is adjusted using the values determined.

Description

The present invention is concerned with a process for the timed control of the liberation of active materials from active material-containing compositions and especially from pharmaceutical compositions.
In pharmaceutical technology, it is known to incorporate active materials into pharmaceutical compositions in such a manner that the active . · materials are liberated from these compositions at a predetermined rate. In this way, it is possible, for example, to achieve a prolongation of the period· of action and thus to avoid too quick and/or too con-, centrated a release of the active material and too high peaks of the blood or tissue levels, which can lead to undesirable side effects.
If the good solubility or, in the case of peroral pharmaceutical products, also the good resorbability of the active material is the reason for too rapid a release, then the resorption of such an active material can be retarded by restricting the original solubility properties. In the simplest case, they can be achieved, for example, in the case of readily soluble substances by admixing poorly soluble adjuvant materials or by coating the substances with adjuvant materials which lower the solubility. Generally speaking, the rule applies that readily water-soluble substances must be worked up with poorly soluble adjuvant -3materials and poorly water-soluble substances with readily soluble or readily swellable adjuvant substances if a good retarding effect is to be achieved.
Such compositions are often additionally coated with diffusion coatings.
It is known that hydrophilic polymers can be used to produce the desired retarding effect.
From J. Pharm. Sci., 55, 974/1965, it is known, for example, that the desired retarding effect depends exclusively upon the formation of a viscous gel barrier which prevents the penetration of digestive juices into the interior of tablets.
Otherwise, hydrophilic polymers have hitherto only been used in pharmaceutical technology as binding agents in aqueous solution for achieving mechanically stable compressed bodies and those with a high swellability have been employed as so-called disintegrating agents for achieving a rapid breakdown of tablets in solid form.
For the expert, it was hitherto very difficult, when using swelling materials, for example guar gum, carob bean meal, semi-synthetic or synthetic polymers, such as silicic acids, cellulose acetate phthalate, hydroxypropylcellulose or carboxypolymethylene (Carbopol), to predict their influence on the liberation of an active substance from a pharmaceutical composition and -4hitherto extensive empirical experiments were first necessary in order to develop a retard form with a previously determined liberation characteristic of the active material.
It is an object of the present invention to adjust the liberation characteristic of retard form with the simplest of means in any desired manner, using a previously unknown principle, and thus to minimise the empirical experiments in the case of developments.
We have now, surprisingly, found that when using hydrophilic polymers, especially carboxymethyleellulose and methylcellulose, the differences of solubility or of swellability, due, perhaps, to the degree of substitution, have only a very small influence on the liberation of active materials from retard pharmaceutical compositions.
The expert would, on the basis of his knowledge of the prior art, actually have expected that in the case of the incorporation of, for example, carboxymethylcellulose into retard compositions, the degree of substitution would ba of considerable importance for the aberosion of compressed bodies and thus the liberation of active material involved therewith since the solubility or swellability of this adjuvant material depends directly upon the degree of substitution so that, -5upon contact with water of digestive juices, due to varyingly strong swelling and loosening up of the pharmaceutical compositions, a greatly differing rate of liberation ought to result. Completely unexpectedly, we have found that the liberation of the active material is essentially determined only by the degree of viscosity of the added hydrophilic polymers, the adjustment of a less retarded liberation of active material taking place, fully surprisingly, with highly viscous polymers, whereas with low viscous polymers the liberation of the active material is more strongly retarded.
Consequently, according to the present invention there is provided a process for the timed control of liberation of active material from a retarded active materialcontaining composition by the addition of a hydrophilic polymer, wherein the rate of liberation of active material which increases with increasing viscosity of the hydrophilic polymer added is empirically determined and the desired liberation characteristic is adjusted using the values so determined.
Especially preferred hydrophilic polymers include carboxymethylcelluloses (synonyms sodium carboxymethylcellulose, CMC, Na-celluloseglycolate) and methyl cellulose, which are widely available commercially.
They differ, on the one hand, by the degree of substitution and, on the other hand, within a certain range of S3 10 4 -6substitution, by the viscosity which, in. turn, is dependent upon the degree of polymerisation or upon the molecular weight. The viscosity of the conventional commercial products is determined in aqueous solution and is type-specified by the manufacturer.
The statements in the present description refer to the data supplied by the manufacturer and depend upon the viscosity determination, published in the Company's brochure of technical data for cellulose gum and its chemical and physical properties (cellulose gum No. 800-6A/G, Hercules, Wilmington, Del., U.S.A.).
Not only by the use of hydrophilic polymers of quite definite viscosity but also by the use of mixtures of polymers with different degrees of viscosity, the rate of liberation of active materials from solid retard compositions can now be varied and fixed in a previously unknown manner. In the case of the use of a thorough'mixing of, for example, carboxymethylcelluloses of differing viscosity, retard pro20 ducts are obtained, the course of liberation of which lies between the courses of liberation which the individual components would have given.
Carboxymethylcelluloses are, therefore, especially preferred for the process according to the present invention because these are commercially available in a large number of degrees of viscosity of from about 0.02 Pa.s. to about 40 Pa.s. and do not give rise to -7any problems with regard to their stability and compatibility with active materials and other adjuvant materials.
The process according to the present invention is advantageous for the development of retard pharmaceutical compositions since the carrying out of a large number of experiments can be avoided. Hitherto, in large series of experiments, it was necessary to find compositions which gave the necessary liberation of the active materials. The formulations were thereby either randomly selected and varied within the series of experiments or, according to a factor search plan, I certain influential factors were sought, each of which had to be varied at different levels. The planned experiments must thereby be carried out, the products obtained investigated and, on the basis of the results, the selection made for the next series of experiments.
When using the process according to the present invention, this work is, as a rule, either not necessary or is substantially reduced in extent; thus, after one preliminary experiment, the probably suitable viscosity stage of, for example, carboxymethylcellulose, can be sought. If the desired degree of active material liberation is thereby not obtained, then, by the use of mixtures of carboxymethylcelluloses with different degrees of viscosity, an appropriate degree of liberation can be adjusted. 310^ -8If this adjustment has taken place, then products are obtained, each of which are the same in their qualitative and quantitative composition and which only differ by the degree of viscosity of the carboxy5 methylcelluloses employed.
Since the products are of uniform composition, the working up properties are also the same. Thus, there is no danger that, in the case of variation of the degree of liberation, as previously, the physical properties, for example, the tabletability, would also change. The active material stability of such products is also the same for all degrees of viscosity and, consequently, no longer has to be separately determined for each variation in prolonged stability tests.
The amount of polymer to be added is, as a mile, from 0.1 to 10% by weight of the total mass of the composition. When using carboxymethylcelluloses, amounts in the range of from 0.5 to 3% by weight are preferred.
' The process according to the present invention can, in principle, also be applied to other active material-containing compositions, for example, animal bait, fertilisers and herbicides.
The following Examples are given for the purpose of illustrating the present invention:Exanrole 1. Ί00 g. of hydrogenated castor oil, 150 g. of -·9stearic acid and 750 g. lactose were homogeneously mixed with 10 g. amounts of carboxymethylcellulose of various stages of viscosity and then melt granulated in known manner. The following viscosity stages were thereby employed: a) 0.05 Pa.s. b) 0.3 Pa.s. c) 0.6 Pa.s. d) 3 Pa.s. e) 6 Pa.s. f) 20 Pa.s. g) 40 Pa.s.
All batches were then pressed with a medium, uniform pressure to give domed tablet's of 11 mm. diameter and 490 mg. weight. The breakdown of the tablets was investigated by the procedure described in the National Formulary XIV, p.935, in simulated gastric and duodenal juice, based upon their loss of weight, the residues of the tablets being determined at time intervale indicated on the abscissa of Figure 1 of the accompanying drawings, dried at 45°C. for 10 hours and weighed.
It can be seen from Figure 1 that the weight loss of the tablets is directly dependent upon the viscosity of the carboxymethylcellulose used.
Example ?.
This Example demonstrates the adjustment of a -10particular active material liberation on the basis of a predetermined specification.
In the manner described in Example 1, tablets were produced with a total weight of 300 mg. and with an active material content of SO mg. (diltiazem hydrochloride). The determination of the active material was made from the liquid medium at the time intervals indicated on the abscissa of Fig.2a of the accompanying drawings. Initially, use was made of a carboxymethylcellulose with a viscosity of 0.3 Pa.s., the results obtained being given in Fig.2a. The desired limits of liberation are shown in Fig.2b.
On the basis of the course of the curve in Fig.1, tablets were then investigated which had been prepared with the use of carboxymethylcellulose with a viscosity of 3 Pa.s. The results of the liberation testing are given in Fig.2c which show that the liberation takes place too quickly. The use of a carboxymethylcellulose with a viscosity of 0.6 Pa.s. gave a liberation characteristic lying exactly within the desired limits (Fig.2d). The same result was obtained when using a mixture of a carboxymethylcellulose with a viscosity of 0.3 Pa.s. with a carboxymethylcellulose with a viscosity of 3.0 Pa.s (see Fig.2e).

Claims (6)

1. CLAIMSs
1. A process for the timed control of the liberation of active material from a retarded active materialcontaining composition by the addition of a hydrophilic 5 polymer, wherein the rate of liberation of active material which increases with increasing viscosity of the hydrophilic polymer added is empirically determined and the desired liberation characteristic is adjusted using the values so determined. 10
2. A process according to Claim 1, wherein the active material is a drug.
3. A process according to Claim 1 or 2, wherein the hydrophilic polymer is methyl cellulose and/or carboxymethylcellulose. 15
4. A process according to any one of Claims 1 to 3, wherein the hydrophilic polymer used has a viscosity of from 0.02 to 40 Pa.s.
5. A process according to any of the preceding claims, wherein the viscosity is adjusted by mixing hydrophilic polymers with 20 different degrees of viscosity to a value lying between these degrees of viscosity. -12
6. A process according to Claim 1 for the timed control of the liberation of active material from a retarded active material-containing composition, substantially as hereinbefore described and exemplified.
IE1201/82A 1981-06-26 1982-05-19 Process for the control of the liberation of active materials from active material containing compositions IE53104B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813125178 DE3125178A1 (en) 1981-06-26 1981-06-26 METHOD FOR THE TIMED CONTROL OF THE RELEASE OF ACTIVE SUBSTANCES FROM ACTIVE SUBSTANCE PREPARATIONS, IN PARTICULAR DRUG PREPARATIONS

Publications (2)

Publication Number Publication Date
IE821201L IE821201L (en) 1982-12-26
IE53104B1 true IE53104B1 (en) 1988-06-22

Family

ID=6135462

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1201/82A IE53104B1 (en) 1981-06-26 1982-05-19 Process for the control of the liberation of active materials from active material containing compositions

Country Status (13)

Country Link
EP (1) EP0068446B2 (en)
JP (1) JPS5843927A (en)
AT (1) ATE16979T1 (en)
AU (1) AU548792B2 (en)
CA (1) CA1208556A (en)
DE (2) DE3125178A1 (en)
DK (1) DK173480B1 (en)
ES (1) ES8308699A1 (en)
FI (1) FI78391C (en)
HU (1) HU189148B (en)
IE (1) IE53104B1 (en)
SU (1) SU1375114A3 (en)
ZA (1) ZA824496B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
GB8403361D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical composition
US4608248A (en) * 1985-11-08 1986-08-26 Warner-Lambert Company Process for time-controlled release of active ingredients
DE3737741A1 (en) * 1987-11-06 1989-05-18 Goedecke Ag ORAL MEDICAL FORM FOR THE ONLY DAILY TREATMENT OF HYPERTENSION WITH DILTIAZEMHYDROCHLORIDE
FR2630913A1 (en) * 1988-05-09 1989-11-10 Delalande Sa DILTIAZEM WATER SOLUBLE SALT (S) COMPRESSES WITH PROGRAMMED RELEASE AND METHOD OF MANUFACTURING THE SAME
ES2036123B1 (en) * 1990-12-03 1994-01-16 Neila Nieto Jorge Juan MANUFACTURING PROCESS OF SOLID INORGANIC FERTILIZERS CONDITIONED WITH WATER RETAINING POLYMERS.
ES2042418B1 (en) * 1992-05-18 1994-07-01 Tecno Holding S A METHOD FOR THE EXTERNAL TREATMENT OF VEGETABLE CROPS.
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
GB2370775A (en) * 2001-01-04 2002-07-10 Nimrod Israely Insecticidal composition based on attractant, insecticide and stabilizer, the outer surface of which expands & loses viscosity on contact with humidity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492019A1 (en) * 1963-06-20 1969-02-20 Ministerul Ind Petrolului Si C Surcharge for medicinal tablets and methods of obtaining them
NL159577B (en) * 1968-02-15 1979-03-15 Organon Nv PROCESS FOR PREPARING FAST DISINTEGRATING SOLID PARTS.
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
CA1208556A (en) 1986-07-29
AU8536182A (en) 1983-01-06
FI78391C (en) 1989-08-10
FI822276A0 (en) 1982-06-24
EP0068446A3 (en) 1983-07-20
ES513422A0 (en) 1983-10-01
EP0068446A2 (en) 1983-01-05
DE3125178A1 (en) 1983-01-13
IE821201L (en) 1982-12-26
FI78391B (en) 1989-04-28
SU1375114A3 (en) 1988-02-15
AU548792B2 (en) 1986-01-02
EP0068446B1 (en) 1985-12-18
ATE16979T1 (en) 1986-01-15
ES8308699A1 (en) 1983-10-01
DK173480B1 (en) 2000-12-18
DE3268012D1 (en) 1986-01-30
FI822276L (en) 1982-12-27
HU189148B (en) 1986-06-30
DK287982A (en) 1982-12-27
ZA824496B (en) 1983-04-27
JPH0569806B2 (en) 1993-10-01
EP0068446B2 (en) 1988-12-07
JPS5843927A (en) 1983-03-14

Similar Documents

Publication Publication Date Title
US3773920A (en) Sustained release medicinal composition
AU598280B2 (en) Sustained release pharmaceutical compositions in oral dosage form
DK170347B1 (en) Molecular coordination complex, process for its preparation, use of the complex in a preparation and preparation containing the complex
US3539380A (en) Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US4971805A (en) Slow-releasing granules and long acting mixed granules comprising the same
US3922339A (en) Sustained release medicant
JP4017664B2 (en) Pharmaceutical composition of conjugated estrogens and methods of use thereof
US4775535A (en) Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
JPH11514332A (en) Sustained-release preparations containing three different types of polymers
EP0188040A1 (en) Slow release solid preparation
US4150110A (en) Coated granules of polyacrylic alkali metal salts and method of producing same
US4608248A (en) Process for time-controlled release of active ingredients
AU1621899A (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
HU195109B (en) Film-creating watery covering dispersion and process for its production
HUT75773A (en) Starch acetate composition with modifiable properties, method for preparation and usage thereof
IE53104B1 (en) Process for the control of the liberation of active materials from active material containing compositions
SE448061B (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL ACTIVE COMPOSITIONS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS COVERED BY THE ACTIVE COMPONENT WITH A POLYMER SOLUTION IN WHICH A WATER PHASE IS DISPERSED
US4761289A (en) Sustained release implant and method for preparing same
AU2005313262B2 (en) Tablets for the sustained release of indapamide and preparation method thereof
JPH09169641A (en) Loxoprofen preparation
DE4341156C1 (en) Use of polymer powders which are redispersible in water as vehicles for drugs
EP0266707A2 (en) Sustained release labetalol tablet
Kane et al. Technological evaluation of three enteric coating polymers I. with an insoluble drug
JPS6084215A (en) Film coating composition for solid pharmaceutical
WO1990004980A1 (en) Drug composition

Legal Events

Date Code Title Description
MK9A Patent expired